Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes. Ballerie A, Nguyen Van R, Lacut K, Galinat H, et al. Thromb Res 2021;208:39-44.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ballerie A, Nguyen Van R, Lacut K, Galinat H, et al. Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes. Thromb Res 2021;208:39-44.
PMID: 34689080